Anna Richo - Net Worth and Insider Trading

Anna Richo Net Worth

The estimated net worth of Anna Richo is at least $13 Million dollars as of 2024-04-27. Anna Richo is the SVP & CCO of Amgen Inc and owns about 49,465 shares of Amgen Inc (AMGN) stock worth over $13 Million. Details can be seen in Anna Richo's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Anna Richo has not made any transactions after 2012-08-01 and currently still holds the listed stock(s).

Transaction Summary of Anna Richo

Anna Richo Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anna Richo owns 3 companies in total, including Adamas Pharmaceuticals Inc (ADMS) , Amgen Inc (AMGN) , and Exelon Corp (EXC) .

Click here to see the complete history of Anna Richo’s form 4 insider trades.

Insider Ownership Summary of Anna Richo

Ticker	Comapny	Transaction Date	Type of Owner
ADMS	Adamas Pharmaceuticals Inc	2020-08-29	director
AMGN	Amgen Inc	2012-08-01	SVP & CCO
EXC	Exelon Corp	2023-08-01	director

Anna Richo Latest Holdings Summary

Anna Richo currently owns a total of 1 stock. Anna Richo owns 49,465 shares of Amgen Inc (AMGN) as of August 1, 2012, with a value of $13 Million.

Latest Holdings of Anna Richo

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
AMGN	Amgen Inc	2012-08-01	49,465	269.98	13,354,561

Holding Weightings of Anna Richo

Anna Richo Form 4 Trading Tracker

According to the SEC Form 4 filings, Anna Richo has made a total of 0 transactions in Amgen Inc (AMGN) over the past 5 years. The most-recent trade in Amgen Inc is the sale of 5,125 shares on August 1, 2012, which brought Anna Richo around $425,682.

Insider Trading History of Anna Richo

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Anna Richo Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Anna Richo Ownership Network

Ownership Network List of Anna Richo

No Data

Ownership Network Relation of Anna Richo

Anna Richo Owned Company Details

What does Adamas Pharmaceuticals Inc do?

Who are the key executives at Adamas Pharmaceuticals Inc?

Anna Richo is the director of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , Chief Financial Officer Christopher B Prentiss , and director & 10 percent owner William W. Ericson .

Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adamas Pharmaceuticals Inc Insider Transactions

No Available Data

What does Amgen Inc do?

Who are the key executives at Amgen Inc?

Anna Richo is the SVP & CCO of Amgen Inc. Other key executives at Amgen Inc include SVP & CCO Nancy A. Grygiel , SVP & Gen. Counsel & Secy. Jonathan P Graham , and VP & Finance & CAO Matthew C. Busch .

Amgen Inc (AMGN) Insider Trades Summary

Over the past 18 months, Anna Richo made no insider transaction in Amgen Inc (AMGN). Other recent insider transactions involving Amgen Inc (AMGN) include a net sale of 2,641 shares made by Nancy A. Grygiel , a net sale of 10,000 shares made by Jonathan P Graham , and a net sale of 9,558 shares made by Murdo Gordon .

In summary, during the past 3 months, insiders sold 0 shares of Amgen Inc (AMGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 22,586 shares of Amgen Inc (AMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 22,586 shares.

Amgen Inc (AMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amgen Inc Insider Transactions

No Available Data

What does Exelon Corp do?

Who are the key executives at Exelon Corp?

Anna Richo is the director of Exelon Corp. Other key executives at Exelon Corp include SVP & Corp Controller Robert A Kleczynski , CEO of BGE Carim V Khouzami , and EVP & CFO Jeanne M Jones .

Exelon Corp (EXC) Insider Trades Summary

Over the past 18 months, Anna Richo made no insider transaction in Exelon Corp (EXC). Other recent insider transactions involving Exelon Corp (EXC) include a net sale of 6,000 shares made by Carim V Khouzami ,

In summary, during the past 3 months, insiders sold 0 shares of Exelon Corp (EXC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,000 shares of Exelon Corp (EXC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,000 shares.

Exelon Corp (EXC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Exelon Corp Insider Transactions

No Available Data

Anna Richo Mailing Address

Above is the net worth, insider trading, and ownership report for Anna Richo. You might contact Anna Richo via mailing address: Amgen Inc., One Amgen Center Drive, Thousand Oaks Ca 91320-1799.

Discussions on Anna Richo

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.